Reacción a "Detected patterns of change in blood cells with age, which could be used to develop anti-ageing therapies"

This landmark study represents a major advance in our ability to understand and monitor ageing at the cellular level. Since ageing is the leading risk factor for a wide range of  diseases —including cancer and neurodegeneration—i t will be interesting to explore how EPI-Clone barcodes shift not only during healthy ageing, but also in the preclinical stages of  disease, before symptoms emerge and when interventions are most likely to be effective.

As such, EPI-Clone could become a valuable tool for assessing the efficacy of emerging anti-ageing therapies, such as senolytics.